Immunocore
Quarterly Financials
| Values in thousands | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 |
|---|---|---|---|---|
Revenue | $103,693 | $97,964 | $93,881 | $84,052 |
Gross Profit | 103,180 | 96,924 | 93,050 | 83,722 |
EBITDA | 4,145 | -6,399 | 9,963 | -15,274 |
EBIT | 3,347 | -7,179 | 9,109 | -16,440 |
Net Income | 785 | -10,300 | 5,023 | -23,771 |
Net Change In Cash | 103,693 | 97,964 | 93,881 | 84,052 |
Free Cash Flow | -5,204 | 25,550 | 137 | -17,535 |
Cash | 498,413 | 487,933 | 476,845 | 455,731 |
Basic Shares | 50,403 | 50,294 | 51,949 | 49,991 |
Annual Financials
| Values in thousands | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|
Revenue | $247,770 | $249,428 | $144,234 | $36,484 |
Gross Profit | 239,382 | 248,391 | 138,940 | 36,484 |
EBITDA | -38,504 | -51,646 | -38,354 | -166,715 |
EBIT | -41,861 | -55,736 | -42,768 | -174,306 |
Net Income | -40,805 | -55,287 | -43,464 | -180,029 |
Net Change In Cash | 247,770 | 249,428 | 144,234 | 36,484 |
Free Cash Flow | 20,888 | -2,485 | -51,412 | -144,492 |
Cash | 455,731 | 442,626 | 402,472 | 321,059 |
Basic Shares | 49,991 | 48,888 | 45,714 | 43,862 |
Earnings Calls
| Quarter | EPS |
|---|---|
2025-12-31 | $0 |
2025-09-30 | -$0.003 |
2025-06-30 | -$0.20 |
2025-03-31 | -$0.49 |
